共 288 条
- [1] Bruix J(2014)Hepatocellular carcinoma: clinical frontiers and perspectives Gut 63 844-855
- [2] Gores GJ(2022)Portal hypertension in nonalcoholic fatty liver disease: from pathogenesis to clinical practice J Clin Transl Hepatol 10 979-985
- [3] Mazzaferro V(2022)Current and investigational drugs in early clinical development for portal hypertension Front Med (Lausanne) 9 182-236
- [4] Nababan SHH(2018)EASL Clinical Practice Guidelines: management of hepatocellular carcinoma J Hepatol 69 1-13
- [5] Lesmana CRA(2019)Impact of clinically significant portal hypertension on outcomes after partial hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis HPB (Oxford) 21 1908-1916
- [6] Sakiani S(2008)Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma Gastroenterology 134 336-343
- [7] Heller T(2019)Possible underestimation of blood loss during laparoscopic hepatectomy BJS Open 3 721-727
- [8] Liu J(2015)Long-term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi-institutional Japanese study J Hepato-Bil Pancreat Sci 22 46-51
- [9] Zhang H(2009)Risk factors and management of ascites after liver resection to treat hepatocellular carcinoma Arch Surg 144 1089-1099
- [10] Xia Y(2017)Pleural effusion after hepatectomy for hepatocellular carcinoma: risk factor analyses and its impact on oncological outcomes World J Surg 41 C268-270